Citation 108898
VAN BEEK,TA: BOMARDELLI,E: MORAZZONI,P: PETERLONGO,F:. (1998). GINKGO BILOBA L.. 69(3)
Citation Details
| Title | GINKGO BILOBA L. |
|---|---|
| Authors | VAN BEEK,TA: BOMARDELLI,E: MORAZZONI,P: PETERLONGO,F: |
| Year | 1998 |
| Volume | 69 |
| Issue | 3 |
Summary
Year: 1998
Journal: Unknown
Organisms and Their Experiments (4)
Unknown organism
Unknown organism
Unknown organism
Ginkgo biloba (GINKGOACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
MISCELLANEOUS EFFECTS
| None |
ACTIVE
|
|
| 3 |
MISCELLANEOUS EFFECTS
| None |
ACTIVE
|
|
| 4 |
MEMORY ENHANCEMENT EFFECT
| None |
ACTIVE
|
|
| 5 |
SEROTONIN (5-HT) AGONIST ACTIVITY
| None |
ACTIVE
|
|
| 6 |
ADRENERGIC AGONIST(ALPHA)
| None |
ACTIVE
|
|
| 7 |
SEROTONIN (5-HT) AGONIST ACTIVITY
| None |
ACTIVE
|
|
| 8 |
MEMORY ENHANCEMENT EFFECT
| None |
ACTIVE
|
|
| 9 |
MEMORY ENHANCEMENT EFFECT
| None |
ACTIVE
|
|
| 10 |
NEUROPROTECTANT EFFECT
| None |
ACTIVE
|
|
| 11 |
MEMORY ENHANCEMENT EFFECT
| None |
ACTIVE
|
|
| 12 |
VESTIBULAR COMPENSATION INCREASE
| None |
ACTIVE
|
|
| 13 |
NEUROPROTECTANT EFFECT
| None |
ACTIVE
|
|
| 14 |
VASODILATOR ACTIVITY
| None |
ACTIVE
|
|
| 15 |
VASOCONSTRICTOR ACTIVITY
| None |
ACTIVE
|
|
| 16 |
VASODILATOR ACTIVITY
| None |
ACTIVE
|
|
| 17 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 18 |
HYDROXIDE RADICAL GENERATION INHIBITION
| None |
ACTIVE
|
|
| 19 |
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
| None |
ACTIVE
|
|
| 20 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 21 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 22 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 23 |
SEROTONIN (5-HT) LEVEL INCREASE
| None |
ACTIVE
|
|
| 24 |
SEROTONIN (5-HT) LEVEL INCREASE
| None |
ACTIVE
|
|
| 25 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 26 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 27 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 28 |
ANTIARRHYTHMIC ACTIVITY
| None |
ACTIVE
|
|
| 29 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 30 |
ANTIAGING ACTIVITY
| None |
ACTIVE
|
|
| 31 |
APOPTOSIS INHIBITION
| None |
ACTIVE
|
|
| 32 |
PROTEIN KINASE C INHIBITION
| None |
ACTIVE
|
|
| 33 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 34 |
ANTIISCHEMIC EFFECT
| None |
ACTIVE
|
|
| 35 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 36 |
ANTIISCHEMIC EFFECT
| None |
ACTIVE
|
|
| 37 |
SUPEROXIDE DISMUTASE STIMULATION
| None |
ACTIVE
|
|
| 38 |
NEUROPROTECTANT EFFECT
| None |
ACTIVE
|
|
| 39 |
NEUROPROTECTANT EFFECT
| None |
ACTIVE
|
|
| 40 |
MEMORY ENHANCEMENT EFFECT
| None |
ACTIVE
|
|
| 41 |
MEMORY RETENTION IMPROVEMENT
| None |
ACTIVE
|
|
| 42 |
MEMORY ENHANCEMENT EFFECT
| None |
ACTIVE
|
|
| 43 |
ANTIISCHEMIC EFFECT
| None |
ACTIVE
|
|
| 44 |
ANTIOXIDANT ACTIVITY
| None |
ACTIVE
|
|
| 45 |
TOXICITY ASSESSMENT(QUANTITATIVE)
| None |
ACTIVE
|
|
| 46 |
TOXICITY ASSESSMENT(QUANTITATIVE)
| None |
ACTIVE
|
|
| 47 |
TERATOGENIC ACTIVITY
| None |
INACTIVE
|
|
| 48 |
TERATOGENIC ACTIVITY
| None |
INACTIVE
|
|
| 49 |
PHARMACOKINETIC STUDY OF
| None |
ACTIVE
|
|
| 50 |
CEREBRAL INSUFFICIENCY IMPROVEMENT
| None |
ACTIVE
|
|
| 51 |
ANTIALZHEIMER'S ACTIVITY
| None |
ACTIVE
|